



Identification of the regulatory genes required for the acid 





B.Sc. Molecular Biology (Hons) 
 
This thesis is presented for the degree of 
Doctor of Philosophy 
 










I hereby declare that, unless otherwise stated, the work presented in this 
































                                  孟郊.游子呤 
    
 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS .............................................................................................. I 
LIST OF PUBLICATIONS ............................................................................................ II 
ABBREVATIONS  ........................................................................................................... III 
ABSTRACT…………………………………………………………………………..…V 
CHAPTER 1 INTRODUCTION ......................................................................................  1 
1.1 Nitrogen Fixation ............................................................................................................................2 
1.2 Biological Nitrogen Fixation ..........................................................................................................2 
1.3 Symbiotic Nitrogen Fixation ..........................................................................................................3 
1.4 The root nodule bacteria ................................................................................................................4 
1.5 The rhizobia-legume symbiosis ......................................................................................................5 
1.5.1  The molecular dialogue between rhizobia and legumes  ............................................................6 
1.5.2  Host specificity within the rhizobia-legume symbioses ............................................................8 
1.6 Classification of rhizobia ................................................................................................................9 
1.7 The genus Sinorhizobium  ..............................................................................................................  10 
1.7.1  S. meliloti ................................................................................................................................  11 
1.7.2  S. medicae ...............................................................................................................................  12 
1.8 Agriculturally important Medicago hosts for Sinorhizobium ....................................................  14  
 
 
1.8.1  Medicago murex L ..................................................................................................................  14 
1.8.2  Medicago polymorpha L .........................................................................................................  15 
1.8.3  Medicago sativa L  ...................................................................................................................  15 
1.8.4  Medicago truncatula Gaertn ...................................................................................................  15 
1.9 Sinorhizobium genes required for nodulation and nitrogen fixation ........................................  16 
1.10 Regulation of symbiotic nitrogen fixation genes in Sinorhizobium .........................................  19 
1.11 Sinorhizobium sigma factors that regulate symbiotic gene expression ...................................  22 
1.11.1  RpoN .......................................................................................................................................  22 
1.11.2  RpoH .......................................................................................................................................  27 
1.12 The impact of soil acidity on Sinorhizobium and the Sinorhizobium-Medicago symbiosis ...  28 
1.13 The acid-tolerant strain S. medicae WSM419 ..........................................................................  29 
1.14 Identification of genes involved in acid tolerance and response in S. medicae WSM419......  31 
1.15 The genome structure of S. medicae WSM419 .........................................................................  34 
1.16 Characterisation of the lpiA and its gene region on pSMED02...............................................  35 
1.16.1  Putative function of LpiA .......................................................................................................  40 
1.16.2  FsrR is a regulator of lpiA expression .....................................................................................  42 
1.17 Research aims  ..............................................................................................................................  43 
CHAPTER 2    INACTIVATION OF ACVB, TCSA, AND LPIA IN S. MEDICAE 
WSM419………………………………………………………..……..…45 
2.1 Introduction  ...................................................................................................................................  46  
 
 
2.2 Materials and Methods .................................................................................................................  50 
2.2.1  Bacterial strains and plasmids .................................................................................................  50 
2.2.2   Primer design and PCR amplification ....................................................................................  50 
2.2.3   PCR product purification .......................................................................................................  53 
2.2.4  Agarose gel electrophoresis ....................................................................................................  53 
2.2.5  Ligation and transformation ....................................................................................................  54 
2.2.6  Plasmid DNA purification by alkaline lysis  ............................................................................  54 
2.2.7  Biparental conjugation ............................................................................................................  55 
2.2.8  Genomic DNA extraction .......................................................................................................  56 
2.2.9  PCR verification of single crossover mutations in S. medicae  ................................................  57 
2.2.10   DNA sequencing  ......................................................................................................................  57 
2.3 Results ............................................................................................................................................  59 
2.3.1  Methodology of single crossover mutagenesis .......................................................................  59 
2.3.2   PCR amplification of tcsA, acvB and lpiA intragenic fragments  .............................................  61 
2.3.3  Screening of pGEM-T recombinants ......................................................................................  61 
2.3.4  Cloning the cassette CAS-1116 into pTRtcsA, pTRacvB and pTRlpiA .................................  66 
2.3.5  Removal of pGEM-T sequence from pTR1116tcsA, pTR1116acvB and pTR1116lpiA ........  68 
2.3.6  Mobilization of plasmid to inactivate the target gene into S. medicae WSM419 ...................  71 
2.3.7  PCR verification of tcsA, acvB, lpiA, tcrA and rpoN single crossover mutations ...................  71 
2.3.8  Sequencing PCR verification products of tcsA, tcrA, acvB, lpiA and rpoN mutants...............  73 
2.4  Discussion .....................................................................................................................................  75 
CHAPTER 3 PHENOTYPIC ANALYSIS OF S. MEDICAE WSM419 
MUTANTS………………………………………………………..…….77 
3.1 Introduction  ...................................................................................................................................  78  
 
 
3.2 Materials and Methods .................................................................................................................  81 
3.2.1  Bacterial strains and plasmids .................................................................................................  81 
3.2.2  Culture preparation for phenotype test ....................................................................................  82 
3.2.3  Stress tolerance tests ...............................................................................................................  82 
3.2.4  Antibiotics tests  .......................................................................................................................  82 
3.2.5  Mean generation time (MGT) determination ..........................................................................  83 
3.2.6  Glasshouse trial .......................................................................................................................  83 
3.2.6.1  Experimental design  ................................................................................................................  83 
3.2.6.2  Preparation of Medicago inoculants  ........................................................................................  84 
3.2.6.3  Pot preparation ........................................................................................................................  84 
3.2.6.4  Seedlings .................................................................................................................................  84 
3.2.6.5  Inoculation of plants and watering schedule ...........................................................................  85 
3.2.6.6  Harvesting the plants  ...............................................................................................................  85 
3.2.7  Statistical analysis ...................................................................................................................  85 
3.3 Results ............................................................................................................................................  87 
3.3.1  Stress tolerance tests ...............................................................................................................  87 
3.3.2  Antibiotic tests ........................................................................................................................  89 
3.3.3  Mean generation time (MGT) determination ..........................................................................  91 
3.3.4  Growth of Medicago in glass house experiments ...................................................................  91 
3.3.5  Effect of inoculation on nodulation of hosts ...........................................................................  92 
3.3.6  Effect of inoculation on dry weight of hosts ...........................................................................  94 
3.4 Discussion ......................................................................................................................................  98 
CHAPTER 4 GENE EXPRESSION STUDIES ..........................................................  103 
4.1 Introduction  .................................................................................................................................  104  
 
 
4.2 Materials and Methods ...............................................................................................................  108 
4.2.1  Bacterial strains and plasmids ...............................................................................................  108 
4.2.2  Triparental conjugation for Cre-mediated excision  ...............................................................  108 
4.2.3  Selection of CAS-1116 excision mutants  ..............................................................................  110 
4.2.4  PCR verification of Cre-mediated loxP at sites excision ......................................................  110 
4.2.5  Mobilization of pWR220-101H into CAS-1116 excised mutants  .........................................  110 
4.2.6  Measurement of GUS activity  ...............................................................................................  111 
4.2.7  RNA extraction .....................................................................................................................  113 
4.2.8  Spectrophotometric quantification of RNA ..........................................................................  114 
4.2.9  RNA formaldehyde-agarose gel electrophoresis  ...................................................................  114 
4.2.10   Primers design for qRT-PCR ................................................................................................  115 
4.2.11   First strand cDNA synthesis..................................................................................................  115 
4.2.12   Quantitative real-time polymerase chain reaction (qRT-RCR) .............................................  116 
4.2.13   Mathematical model for qRT-PCR data analysis ..................................................................  116 
4.3  Results .........................................................................................................................................  117 
4.3.1  Excision of CAS-1116 from S. medicae mutants using the Cre/loxP system .......................  117 
4.3.2  PCR verification of putative CAS-1116 excision mutants ....................................................  117 
4.3.3  Mobilization of a plasmid borne lpiA-gusA fusion into MUR2122, MUR2128 and MUR2125 
  ……………………………………………………………………………………………….120 
4.3.4  Expression studies  .................................................................................................................  120 
4.3.5  qRT-PCR...............................................................................................................................  122 
4.3.5.1   RNA quantification ...............................................................................................................  122 
4.3.5.2  Confirmation of primer specificity  ........................................................................................  123 
4.3.5.3  PCR amplification efficiencies for each primer pair .............................................................  124 
4.3.5.4  Calculation of the ratio of gene expression at low pH compared to neutral pH  ....................  126 
4.4 Discussion ....................................................................................................................................  129  
 
 
CHAPTER 5 LPIA PROMOTER LOCALIZATION BY 5
′ RACE 
ANALYSIS…………………………………………………………….135 
5.1 Introduction  .................................................................................................................................  136 
5.2 Materials and Methods ...............................................................................................................  140 
5.2.1  Bacterial strains and plasmids ...............................................................................................  140 
5.2.2  RNA extraction .....................................................................................................................  140 
5.2.3  5′ RACE ................................................................................................................................  141 
5.2.3.1  First-strand cDNA synthesis .................................................................................................  141 
5.2.3.2  cDNA purification.................................................................................................................  142 
5.2.3.3  Amplification of cDNA ........................................................................................................  143 
5.2.3.4  Poly (A) Tailing of First-strand cDNA .................................................................................  143 
5.2.3.5  Nested PCR Amplification of dA-tailed cDNA ....................................................................  144 
5.2.3.6  Cloning the nested PCR product into pGEM-T easy vector .................................................  144 
5.2.3.7  DNA sequencing ...................................................................................................................  145 
5.2.4  Identification of RpoN enhancer binding protein (EBP) genes in S. medicae WSM419 ......  145 
5.3 Results ..........................................................................................................................................  146 
5.3.1  Gene specific primer design for lpiA 5′ RACE .....................................................................  146 
5.3.2  cDNA synthesis using lpiA 6651 (SP1) primer ....................................................................  146 
5.3.3  Nested PCR ...........................................................................................................................  147 
5.3.4  Cloning nested PCR product into pGEM-T easy vector .......................................................  148 
5.3.5  Sequencing analysis to determine the lpiA transcription start site ........................................  148 
5.3.6  Gene specific primer design for 5′ RACE analysis of the acvB gene ...................................  148 
5.3.7  cDNA synthesis using acvB4552R (SP1) primer..................................................................  150 
5.3.8  Nested PCR ...........................................................................................................................  152 
5.3.9  Cloning and sequencing analysis to determine the acvB transcription start site ...................  154  
 
 
5.3.10   Identification of the lpiA and acvB promoter ........................................................................  155 
5.3.11   Prediction of a possible RpoN enhancer binding protein (EBP) for the expression of lpiA  ..  155 
5.4 Discussion ....................................................................................................................................  168 
CHAPTER 6 GENERAL DISCUSSION .....................................................................  172 
6.1 The main findings of the thesis ..................................................................................................  174 
6.2 A model of lpiA/acvB regulation in S. medicae WSM419 ........................................................  180 
6.3 Future research directions .........................................................................................................  185 




Firstly, I would like to express my sincere thanks to my principal supervisor Dr. Wayne 
Reeve  for  providing  me  with  the  opportunity  to  complete  my  PhD  study  under  his 
professional supervision. His broad knowledge and patience has been a great help to me 
and enabling me to overcome all the difficulties I have encountered. Secondly, special 
thanks go to my other supervisors Dr. Ravi Tiwari and Dr. Lambert Bräu. You both have 
given me excellent advice in my research. I would also like to thank Dr. Graham O'Hara 
for his kind support to me, as an international student, throughout my PhD studies at 
Murdoch University. 
 
I would like to thank the members of Center for Rhizobium Studies and other scientist 
friends for sharing their research experiences, providing valuable feedback on my work, 
and most importantly, always being very encouraging and making me feel motivated to 
complete my studies.  
 
Also,  I  would  like  to  thank  my  non-scientist  friends  for  always  providing  me  great 
company and allowing me escape from my work to see other beautiful things in life. 
Finally, I am most of all grateful to my parents for their support and understanding that 
their daughter has not been able to be with them for so many years. However, my heart 






LIST OF PUBLICATIONS  
Conference Contributions 
1)  Rui  T,  Tiwari,  R.P.,  Bräu,  L.,  O'Hara,  G.,  Howieson,  J.G.  and  Reeve, 
W.G.(2009): Characterization of the regulatory circuit required for the low pH 
induction  of  the  adaptive  tolerance  response  protein  LpiA  in  Sinorhizobium 
medicae WSM419. Proceeding of the 16th International Congress on Nitrogen 
Fixation. June 14-19, 2009. Big Sky, Montana.USA 
 
2)  Rui  T,  Tiwari,  R.P.,  Bräu,  L.,  O'Hara,  G.,  Howieson,  J.G.  and  Reeve,  W.G. 
(2009): Regulatory circuit of the acid response protein LpiA in Sinorhizobium 
medicae  WSM419.  Proceeding  of  the  15th  Australian  Nitrogen  Fixation 
Conference. Nov 8-13, 2009. Margaret River, Western Australia. 
 
3)  Rui  T,  Tiwari,  R.P.,  Bräu,  L.,  O'Hara,  G.,  Howieson,  J.G.  and  Reeve,  W.G. 
(2011). Identification of the regulatory genes required for the acid activation of 
the low pH inducible gene lpiA in Sinorhizobium medicae. Proceeding of the 
16th International Congress on Nitrogen Fixation. Nov 27-Dec 1, 2011. 2011. 
Fremantle, Western Australia. 
 
It is anticipated that two papers will be published from the material presented in this 




 µ                                              Micro 
A260nm                                       Absorbance at λ = 260 nm  
A280nm                                       Absorbance at λ = 280 nm  
AM3                                         Antibiotic medium 3  
ANOVA                                   Analysis of variance 
ATP                                          Adenosine triphosphate 
       bp                                              Base pair  
CATB                                       Hexadecyltrimethyl ammonium bromide 
d                                                Day(s) 
DEPC                                        Diethylpyrocarbonate  
DNA                                          Deoxyribonucleic acid 
DNase                                        Deoxyribonuclease 
dNTPs                                        Deoxynucleoside triphosphates 
DTT                                           Dithiothreitol 
EDTA                                        Ethylenediamine tetraacetic acid  
g                                                 Centrifugal force   
g                                                Gram 
h                                                Hour(s) 
HEPES                                      4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IPTG                                         Isopropyl β-D-1-thiogalactopyranoside 
kb                                              kilo base pairs 
L                                                Litre   
LB                                             Luria-Bertani  
M                                               Molar 
MES                                          2-(N-morpholino) ethanesulfonic acid 
mg                                             Milligram 
min                                            Minute(s) 
MOPS                                       3-(N-morpholino) propanesulfonic acid  
iv 
 
MW                                          Molecular weight  
n                                               Nano 
ºC                                             Degree Celsius 
OD600nm                                    Optical density at λ = 600 nm  
ONPG                                     ortho-Nitrophenyl-β-galactoside 
PCR                                         Polymerase chain reaction  
RNA                                        Ribonucleic acid 
RNase                                      Ribonuclease 
rpm                                          Revolutions per minute  
s                                               Second(s) 
SDS                                         Sodium dodecyl sulfate  
TAE                                         Tris, acetic acid EDTA 
Tn5                                          Transposon 5  
Tris                                          Tris(hydroxymethyl)aminomethane  
TY                                           Tryptone yeast 
UV                                           Ultra-violet 
V                                              Volt(s) 
X-Gal                                      5-bromo-4-chloro-indolyl-β-D-galactopyranoside 
X-Glc                                      5-bromo-4-chloro-3-indolyl-β-D-glucuronic acid  




The study of low pH responsive gene expression in Sinorhizobium medicae has identified 
many genes that are regulated in response to acidic conditions. One of these, the lpiA 
(low pH inducible gene A) gene, is acid-activated at least twenty fold by low pH and not 
by any other stress. The acid-activated expression of lpiA has been shown to require 
functional FsrR (fused sensor-regulator). However, even in the absence of FsrR, there is 
still a 6-fold acid-induction of lpiA revealing that other proteins are required for the acid-
activation process. Such regulators could be encoded by tcsA (two component sensor 
gene A) and tcrA (two component regulator gene A) which are located upstream of fsrR in 
the lpiA gene region. Furthermore, the identification of a potential sigma factor binding 
motif upstream of lpiA suggested the requirement for RpoN (RNA polymerase sigma 
factor for nitrogen metabolism) for the transcription process. These regulatory proteins 
may also be required for the transcription of the acvB (acid virulence induced gene B) 
since the DNA sequence contains a lpiA stop codon that is coupled to the acvB start 
codon. This would infer that these two genes constitute an operon. It was the aim of this 
work  to  therefore  investigate  the  additional  regulatory  aspects  critical  for  the  acid 
activation of lpiA and to identify if the lpiA and acvB genes are co-transcribed in response 
to acid. 
 
Mutations were constructed by inserting the CAS-1116 cassette into the tcsA, acvB and 
lpiA  genes  of  S.  medicae  WSM419  to  create  the  mutants  MUR2121,  MUR2124  and 
MUR2127,  respectively. Each mutant  was  constructed by single crossover insertional  
vi 
 
inactivation to disrupt the targeted gene and to enable expression to be monitored in each 
background. In addition, mutants were obtained from previous studies carrying single 
crossover mutations in tcrA, rpoN and fsrR.  
 
Phenotypic characterization of tcsA, tcrA, fsrR, acvB, lpiA and rpoN mutants revealed 
that these genes are not required for resistance to ZnCl2 (up to 0.7 mM), CdCl2 (up to 
0.175  mM),  CuSO4  (up  to  1.75  mM),  NaN3  (up  to  0.175  ml)  or  ethanol  (7%)  in 
comparison to the wild-type WSM419. These genes were also found not to be essential 
for cell growth in moderately acidic conditions (pH 5.7). However, it was found that a 
mutation in lpiA or rpoN slightly decreased the growth rate of the mutants when they 
were  exposed  to  pH  5.7.  Furthermore,  in  comparison  to  the  wild-type  S.  medicae 
WSM419, the two mutants were more sensitive to the antibiotic polymyxin B, and were 
only  marginally  more  sensitive  to  the  antibiotics  vancomycin,  bacitracin  and 
spectinomycin at pH 5.7. In addition, it was also discovered that the mutation in rpoN, 
but not lpiA, caused a symbiotic nitrogen fixation defect for the hosts Medicago sativa, 
Medicago murex, Medicago polymorpha and Medicago truncatula. 
 
All of the above-mentioned mutants described were constructed by the insertion of a 
CAS-1116 cassette into the targeted gene. The promoterless gusA reporter was used to 
describe enable transcription to be monitored at the point of insertion. ß-glucuronidase 
(GUS) determinations at pH 7.0 and pH 5.7 revealed that all of the CAS-1116 induced 
fusions, including that to lpiA, were constitutively expressed in the conditions tested. This 
finding  indicated  the  unexpected  existence  of  a  strong  unidentified  promoter  in  the  
vii 
 
cassette sequence upstream of gusA. Expression of each gene was therefore measured in 
cells  cultured  at  pH  7.0  and  pH  5.7  using  the  qRT-PCR  technique.  This  technique 
confirmed the acid-induction of lpiA and revealed that acvB was also acid-activated to the 
same extent. This result reinforced the concept that acvB was co-transcribed with lpiA in 
S.  medicae.  In  contrast,  tcsA,  tcrA,  fsrR  and  rpoN  were  shown  to  be  constitutively 
transcribed with respect to pH.  
 
To investigate the expression of lpiA in each mutant, gusA negative backgrounds were 
constructed. The CAS-1116 cassette (flanked by loxP sites) was excised from MUR2121 
(tcsA:CAS-1116), MUR2124 (acvB:CAS-1116), MUR2090 (tcrA:CAS-1116), MUR2127 
(lpiA:CAS-1116) and MUR2088 (rpoN:CAS-1116) by Cre-mediated recombination. The 
resulting  S.  medicae  mutants  MUR2122,  MUR2125,  MUR2092,  MUR2128,  and 
MUR2093 contained ΔCAS-1116 loxP mutations in tcsA, acvB, tcrA, lpiA and rpoN, 
respectively. To monitor the expression of lpiA in these backgrounds, a plasmid borne 
lpiA-gusA  fusion  located  on  pWR220-101H  was  mobilized  into  the  deletion  mutant 
backgrounds MUR2122, MUR2125, MUR2092, MUR2128 and MUR2093 to create the 
strains MUR2123, MUR2126, MUR2094, MUR2129 and MUR2095, respectively. The 
expression of the plasmid borne lpiA-gusA fusion was examined in each mutant cultured 
at low and neutral pH. The fusion was partially induced at pH 5.7 in MUR2092 (~6-fold) 
and  MUR2125  (~10-fold)  revealing  that  TcrA  and  AcvB  both  act  positively  to  acid 
activate  lpiA  transcription.  The  expression  of  the  lpiA-gusA  fusion  in  MUR2122  or 
MUR2092 was totally abolished revealing that both TcsA and RpoN are essential for lpiA 
expression.  This  result  confirmed  a  role  for  RpoN  and  revealed  for  the  first  time  a  
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specific sigma factor that is required for pH regulated gene expression in S. medicae. 
Furthermore, the finding provided credence to  the suggestion that the putative RpoN 
binding motif located upstream of lpiA may in fact be the lpiA promoter.  
 
To  further  reinforce  this  concept,  the  start  site  of  acid–induced  transcription  was 
determined  using  the  5′  Rapid  Amplification  of  cDNA  ends  (RACE)  technique.  The 
transcription start site for both lpiA and acvB was found to occur 206 bp upstream of the 
lpiA  start  codon.  The  rpoN  binding  site  (5′-TGGCACG-N4-TTGCW-3′)  was  located 
adjacent to this identified transcription start site but with the bold G and C in the motif 
positioned  -27  and  -14  bases  upstream  of  the  transcription  start  site  rather  than  the 
expected  positioning  at  -24  and  -12.  RpoN  is  known  to  have  a  requirement  for  an 
enhancer  binding  protein  (EBP)  to  form  the  open  form  complex  required  for 
transcriptional  activation.  A  bioinformatics  search  against  the  WSM419  genome  for 
proteins carrying a sigma54_interaction domain (Pfam accession number: pfam00158) 
revealed that the gene product of Smed_5956, located upstream of tcsA, is a putative EBP. 
Future work could investigate whether it is this EBP, or another, that is required for the 
expression of the lpiA/acvB operon. 
  
The results presented reveal that the expression of the low pH induced lpiA/acvB operon 
is regulated in a multifaceted way. Interestingly, weak induction of lpiA occurs in the 
absence of TcrA or FsrR. Since induction was totally abolished in a TcsA mutant, this 
could infer that TcsA is the cognate sensor for each of these two-component regulatory 
proteins. In addition, full expression of lpiA was shown to occur only if the RpoN sigma  
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factor was present. This is the first report that has detailed a role for the alternative sigma 
factor RpoN to  regulate the transcription  of acid-induced  genes.  The findings  of this 
thesis have been used to construct a model for the lpiA acid-induced regulatory circuit 
and the implications of this model are discussed. 